Then, to illustrate the relationships between LETM1 expression and clinicopathological features as well as overall survival time in HCC patients, immunohistochemistry was conducted to detect the expression of LETM1 in 82 HCC patients (eight patients’ clinical data and follow-up data were unavailable). Here, LETM1 is linked to hepatocellular carcinoma.